Device Trial Radar · NCT04207554
Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test
Last checked: Nov 21, 2026Latest source record: Jan 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
132
Actual
Start
Dec 5, 2019
Primary completion
Dec 29, 2020
Study completion Dec 29, 2020
Sponsor
- Lead sponsor
- Guangzhou Wondfo Biotech Co., LtdNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Nova Clinical Solutions, Inc.
- First posted
- Dec 23, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the agreement of the test device (Preview® hCG Urine/Serum Combo Pregnancy Test) with the predicate device, the QuickVue+ hCG Combo Test.
Conditions
- Pregnancy
Interventions
Test Device-Strip FormatDevice
Sponsor's investigational device
Test Device-Cassette FormatDevice
Sponsor's investigational device
Predicate DeviceDevice
Commercially available device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall percent (%) agreementTime frame: 3 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
National Insitute of Clinical Research
Garden Grove, California
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.